The George Institute For Global Health
Global
United Kingdom
India
China
Australia

News and Events

Media release: 
05/11/2018

A toolkit that aims to combat road traffic injuries, the leading global killer among older school-age children and adolescents, has been launched at the World Conference on Injury Prevention and Safety Promotion in Bangkok.

The George Institute for Global Health has been designated a World Health Organization (WHO) Collaborating Centre in Injury Prevention and Trauma Care.

Nurses can play a key role in addressing the global injury epidemic, which kills five million people around the world every year, The George Institute for Global Health UK’s Senior Research Fellow Margie Peden told the 3rd Global Conference on Emergency Nursing & Trauma Care on 5th October.

Event
Tuesday, 9 October, 2018 - 13:00 to 17:00
Exhibition Centre Room 19
ACC Liverpool
L3 4FP
Media release: 
04/10/2018

The George Institute for Global Health India today hosted a showcase of its SMARThealth technology, designed to help community health workers identify and treat people at high risk of chronic conditions such as diabetes and heart disease.

Sensyne Health has acquired the SUPPORT-HF™ digital health software developed by researchers at The George Institute for Global Health at the University of Oxford. SUPPORT-HF has been designed to help patients and clinicians in managing heart failure and curate data for medical research using clinical Artificial Intelligence (AI).

by Professor Robyn Norton, Principal Director, The George Institute for Global Health

Media release: 
13/09/2018
High BP and Aotic valve disease

New research has found that long-term exposure to high blood pressure is associated with an increased risk of aortic valve disease, with significant implications for clinical practice guidelines and health management.

Media release: 
15/08/2018

A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world. A trial led by The George Institute for Global Health revealed that most patients – 70 per cent – reached blood pressure targets with the ‘Triple Pill’, compared to just over half receiving normal care.

Pages